Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

188
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
188
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

481
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
481

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the ISG15+STAT1+ monocyte-driven inflammatory storm with Fedratinib in traumatic lung injury via the JAK2/STAT3/PIM1 axis.

Frontiers in immunology·2026
Same author

Technology-driven revolution in CO<sub>2</sub> fixation: From natural pathways to programmable Biosystems.

Biotechnology advances·2026
Same author

Psychiatric and neurological predictors of early ADHD medication discontinuation across the lifespan: a multinational study.

BMJ mental health·2026
Same author

Microglia-Dependent BDNF Signaling in the Dentate Gyrus Underlies the Antidepressant Effects of Gardiquimod, a Toll-Like Receptor 7 Agonist, in Chronically Stressed Mice.

Neurochemical research·2026
Same author

High-Precision LCCD-Based Focus Metrology for I-Line Lithography: Multi-Sample Repeatability and Adaptability Evaluation.

Micromachines·2026
Same author

Engineered Bacillus subtilis for high-yield nattokinase production and therapeutic potential in obesity management.

Journal of animal science and biotechnology·2026

Related Experiment Video

Updated: Jul 1, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Improved neural network with multi-task learning for Alzheimer's disease classification.

Xin Zhang1, Le Gao1, Zhimin Wang1

  • 1School of Electronic and Information Engineering, Wuyi University, Jiangmen, 529000, China.

Heliyon
|March 4, 2024
PubMed
Summary
This summary is machine-generated.

A new AI model, ADnet, improves Alzheimer's disease (AD) detection from MRI scans. This enhanced neural network shows significant accuracy gains, aiding early diagnosis and intervention for AD and mild cognitive impairment (MCI).

Keywords:
Alzheimer's diseaseMulti-task learningVGG16 network

More Related Videos

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.9K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Related Experiment Videos

Last Updated: Jul 1, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.9K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Area of Science:

  • Artificial Intelligence
  • Medical Imaging
  • Neurology

Background:

  • Alzheimer's disease (AD) presents a major health challenge with limited treatment options.
  • Early detection of AD is critical for timely intervention and management.
  • Current diagnostic methods can be invasive or lack sufficient sensitivity.

Purpose of the Study:

  • To develop and evaluate an enhanced neural network, ADnet, for improved Alzheimer's disease detection using MRI scans.
  • To investigate the efficacy of incorporating depthwise separable convolutions, ELU activation, and SE modules in a VGG16-based model for AD classification.
  • To assess the impact of auxiliary regression tasks on the primary classification performance.

Main Methods:

  • Utilized a VGG16-based neural network architecture, termed ADnet.
  • Implemented depthwise separable convolutions to reduce model parameters.
  • Replaced ReLU with ELU activation and integrated Squeeze-and-Excitation (SE) modules for enhanced feature extraction.
  • Employed multi-task learning, including clinical dementia and mental state score regression alongside MRI classification.

Main Results:

  • ADnet demonstrated a 4.18% accuracy improvement over baseline VGG16 for Alzheimer's disease (AD) vs. Cognitive Normal (CN) classification.
  • Achieved a 6% accuracy improvement for Mild Cognitive Impairment (MCI) vs. CN classification.
  • The integrated SE module enhanced feature extraction efficiency for improved diagnostic accuracy.

Conclusions:

  • ADnet offers a promising advancement in AI-driven early detection of Alzheimer's disease from MRI data.
  • The architectural enhancements and multi-task learning strategy significantly improve classification accuracy.
  • This approach provides valuable support for medical professionals in the early diagnosis and intervention of AD and MCI.